Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2001

View Archived Issues

New series of chemokine receptor-binding compounds and uses reported by AnorMED

Modulators of dopamine neurotransmission presented in recent patents

ADIR patents novel treatments for endothelial dysfunction

Three related series of PDE4 inhibitors in development at Icos

Endothelin receptor antagonists identified by Actelion team

Liver-specific MRI contrast agent launched in Sweden

Modified second-generation taxoids: design and SAR discussed at ACS

Pfizer presents new sulfonamide-based compounds with high selectivity for MMP-3

Simplified salicylihalimide analogues which retain antitumor activity

BTG obtains rights to ANF peptide technology from Genentech

Antidiabetic effects of GW-0072, a new SPARM, examined in animal model of type 2 diabetes

Zeria licenses rights to Visicol from InKine

Glucose excursion decreased, formation of new beta-cells enhanced by DPP IV inhibitor

Jomed and Oxigene form collaboration on restenosis inhibitors

Positive results obtained in phase II Chronogesic trial for long-term pain relief

Orally active NO-independent sGC stimulators from Bayer with vasodilating and hypotensive activity

HGS initiates new clinical trial with repifermin for treatment of mucositis

Janssen seeks FDA approval of new long-acting Risperdal formulation

Ortec's OrCel approved for healing donor site wounds in burn victims

Phase I trials commence for another peripheral kappa opioid receptor agonist from Adolor

Epicyte and Dow collaborate with Centocor on production of therapeutic MAbs in plants

New HCV target discovered at Myriad Genetics, drug development program initiated

WHI-P131: a dual-acting antileukemic, anti-GVHD compound targeting JAK3

Cellegy seeks MCA approval of Rectogesic for treatment of anal fissures

Data from first study in female Fabry's disease patients discussed at recent workshop

Maxygen and InterMune to develop next-generation interferon gamma products

Pivotal trials of daptomycin advance in anticipation of 2003 launch

Gene transfer of COX-1 proves to restore PGI2 synthesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...